Principles of pulmonary protection in heart surgery

By reading, you can know the knowledge and things more, not only about what you get from people to people. Book will be more trusted. As this principles of pulmonary protection in heart surgery, it will really give you the good idea to be successful. It is not only for you to be success in certain life you can be successful in everything. The success can be started by knowing the basic knowledge and do actions.

[1]  J Stocks,et al.  Measurement of lung volumes by plethysmography. , 1997, The European respiratory journal.

[2]  J. Mead,et al.  Surface tension as a factor in pulmonary volume-pressure hysteresis. , 1957, Journal of applied physiology.

[3]  J. Davis,et al.  THE ASSESSMENT OF DIAPHRAGM FUNCTION , 1977, Medicine.

[4]  T. Kooistra,et al.  Progress of fibrinolysis during tumor necrosis factor infusions in humans. Concomitant increase in tissue-type plasminogen activator, plasminogen activator inhibitor type-1, and fibrin(ogen) degradation products. , 1990, Blood.

[5]  K. Takatsuki,et al.  Determination of plasma soluble fibrin using a new ELISA method in patients with disseminated intravascular coagulation , 1996, American journal of hematology.

[6]  R. Mentzer,et al.  The effects of dopamine and isoproterenol on the pulmonary circulation. , 1976, The Journal of thoracic and cardiovascular surgery.

[7]  P. Thistlethwaite,et al.  Pulmonary thromboendarterectomy combined with other cardiac operations: indications, surgical approach, and outcome. , 2001, The Annals of thoracic surgery.

[8]  J. T. Horan,et al.  Fibrin degradation products, fibrin monomer and soluble fibrin in disseminated intravascular coagulation. , 2001, Seminars in thrombosis and hemostasis.

[9]  A. Menichetti,et al.  Successful weaning from cardiopulmonary bypass with central venous prostaglandin E1 and left atrial norepinephrine infusion in patients with acute pulmonary hypertension. , 1999, Critical care medicine.

[10]  J Ean,et al.  Efficacy and safety of recombinant human activated protein C for severe sepsis. , 2001, The New England journal of medicine.

[11]  J. Vincent,et al.  Time course of platelet counts in critically ill patients , 2002, Critical care medicine.

[12]  A. Hoffbrand,et al.  Induction of tissue factor expression in human monocyte/endothelium cocultures , 1995, British journal of haematology.

[13]  Umberto Lucangelo,et al.  Static pressure–volume curves of the respiratory system: were they just a passing fad? , 2008, Current opinion in critical care.

[14]  P. Thistlethwaite,et al.  Outcomes of pulmonary endarterectomy surgery. , 2006, Seminars in thoracic and cardiovascular surgery.

[15]  A. Groeneveld,et al.  Effect of dopamine vs norepinephrine on hemodynamics in septic shock. Emphasis on right ventricular performance. , 1989, Chest.

[16]  J. Moxham,et al.  The measurement of inspiratory muscle strength by sniff esophageal, nasopharyngeal, and mouth pressures. , 1989, The American review of respiratory disease.

[17]  R. Bick.  Disseminated intravascular coagulation. Objective criteria for diagnosis and management. , 1994, The Medical clinics of North America.

[18]  A. Chang,et al.  Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock. , 1993, The Journal of clinical investigation.

[19]  Fumito Ichinose,et al.  Selective Pulmonary Vasodilation Induced by Aerosolized Zaprinast , 1998, Anesthesiology.

[20]  I. McMurtry.  Introduction: pre- and postnatal lung development, maturation, and plasticity. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[21]  V. Pettilä,et al.  Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation 1 , 2004, Journal of thrombosis and haemostasis : JTH.

[22]  E. Buffolo,et al.  Lung perfusion during cardiac surgery with cardiopulmonary bypass: is it necessary? , 2008, Interactive cardiovascular and thoracic surgery.

[23]  R. McIntyre,et al.  Adenosine effectively controls pulmonary hypertension after cardiac operations. , 1996, The Annals of thoracic surgery.

[24]  N. MacIntyre,et al.  Evidence-based ventilator weaning and discontinuation. , 2004, Respiratory care.

[25]  E. de Jonge,et al.  Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation* , 2004, Critical care medicine.

[26]  Suk Ki Hong,et al.  Possible errors using esophageal balloon in determination of pressure-volume characteristics of the lung and thoracic cage , 1959 .

[27]  D. Langleben,et al.  Pulmonary Arterial Hypertension: Pathophysiology and Anesthetic Approach , 2003, Anesthesiology.

[28]  P. Thistlethwaite,et al.  Venovenous extracorporeal life support after pulmonary endarterectomy: indications, techniques, and outcomes. , 2006, The Annals of thoracic surgery.

[29]  Koji Suzuki,et al.  Hemostatic study before onset of disseminated intravascular coagulation , 1993, American journal of hematology.

[30]  J. Fozard,et al.  Determinants of maximal inspiratory pressure. The Baltimore Longitudinal Study of Aging. , 1998, American journal of respiratory and critical care medicine.

[31]  R. Cody,et al.  Dose response to nitric oxide in adult cardiac surgery patients. , 2001, Journal of clinical anesthesia.

[32]  G. Bernard,et al.  Extended evaluation of recombinant human activated protein C United States Trial (ENHANCE US): a single-arm, phase 3B, multicenter study of drotrecogin alfa (activated) in severe sepsis. , 2004, Chest.

[33]  M. Siobal.  Aerosolized prostacyclins. , 2004, Respiratory care.

[34]  K. Moser,et al.  Perfusion scan findings understate the severity of angiographic and hemodynamic compromise in chronic thromboembolic pulmonary hypertension. , 1988, Chest.

[35]  Konstantin Nikolaou,et al.  Pulmonary arterial hypertension: diagnosis with fast perfusion MR imaging and high-spatial-resolution MR angiography--preliminary experience. , 2005, Radiology.

[36]  M. Nakagawa,et al.  Clinical evaluation of low-molecular-weight heparin (FR-860) on disseminated intravascular coagulation (DIC)--a multicenter co-operative double-blind trial in comparison with heparin. , 1993, Thrombosis research.

[37]  N. Syabbalo.  Assessment of respiratory muscle function and strength. , 1998, Postgraduate medical journal.

[38]  STANDARDIZATION of definitions and symbols in respiratory physiology. , 1950, Federation proceedings.

[39]  J. Escolar,et al.  Lung hysteresis: a morphological view. , 2004, Histology and histopathology.

[40]  J. Goerke,et al.  Pre- and Postnatal Lung Development, Maturation, and Plasticity Effects of oligohydramnios on lung growth and maturation in the fetal rat , 2002 .

[41]  H. Büller,et al.  Recombinant human activated protein C resets thrombin generation in patients with severe sepsis – a case control study , 2005, Critical care.

[42]  C. Toh,et al.  Performance and prognostic importance of a new clinical and laboratory scoring system for identifying non-overt disseminated intravascular coagulation , 2005, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[43]  M. Buyukates,et al.  Right-to-left shunt through a patent foramen ovale left open in the management of acute right heart failure after heart transplantation. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[44]  J Clausen,et al.  Measurement of absolute lung volumes by imaging techniques. , 1997, The European respiratory journal.

[45]  G. Gibson,et al.  Lung volumes and elasticity. , 2001, Clinics in chest medicine.

[46]  P. Macklem,et al.  A model of inspiratory muscle mechanics. , 1983, Journal of applied physiology: respiratory, environmental and exercise physiology.

[47]  R. Rossaint,et al.  Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. , 2005, The New England journal of medicine.

[48]  D. Ansley,et al.  Amrinone versus Dobutamine in Cardiac Surgical Patients with Severe Pulmonary Hypertension after Cardiopulmonary Bypass: A Prospective, Randomized Double-Blinded Trial , 1997, Anaesthesia and intensive care.

[49]  R. Bolman,et al.  Prostaglandin E1 for treatment of elevated pulmonary vascular resistance in patients undergoing cardiac transplantation. , 1989, Transplantation proceedings.

[50]  W. Ray.  Learning from aprotinin--mandatory trials of comparative efficacy and safety needed. , 2008, The New England journal of medicine.

[51]  O. Ratnoff.  Epsilon aminocaproic acid--a dangerous weapon. , 1969, The New England journal of medicine.

[52]  P. Thistlethwaite,et al.  Tricuspid valvular disease in the patient with chronic pulmonary thromboembolic disease , 2003, Current opinion in cardiology.

[53]  J. H. Comroe,et al.  A rapid plethysmographic method for measuring thoracic gas volume: a comparison with a nitrogen washout method for measuring functional residual capacity in normal subjects. , 1956, The Journal of clinical investigation.

[54]  S. Mohr-Kahaly,et al.  Assessment of cardiac performance using Tei indices in patients undergoing pulmonary thromboendarterectomy. , 2002, The Annals of thoracic surgery.

[55]  Yasuhiro Ohtomo,et al.  A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: Comparing current criteria* , 2006, Critical care medicine.

[56]  H. Halliday,et al.  Surfactants: past, present and future , 2008, Journal of Perinatology.

[57]  K. Moser,et al.  Chronic, Massive Thrombotic Obstruction of the Pulmonary Arteries: Analysis of Four Operated Cases , 1965, Circulation.

[58]  W. Colucci.  Cardiovascular effects of milrinone. , 1991, American heart journal.

[59]  P. Karaca,et al.  A comparison of the acute hemodynamic effects of inhaled nitroglycerin and iloprost in patients with pulmonary hypertension undergoing mitral valve surgery. , 2006, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

[60]  W. Zin,et al.  Understanding the mechanisms of lung mechanical stress. , 2006, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[61]  M. Blombäck,et al.  Soluble fibrin: A predictor for the development and outcome of multiple organ failure , 1994, American journal of hematology.

[62]  C. S. Lee,et al.  The effect of phenylephrine and norepinephrine in patients with chronic pulmonary hypertension* , 2002, Anaesthesia.

[63]  T. van der Poll,et al.  Regulatory role of cytokines in disseminated intravascular coagulation. , 2001, Seminars in thrombosis and hemostasis.

[64]  A. Jatene,et al.  Low doses of inhaled nitric oxide in heart transplant recipients. , 1996, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[65]  A. Klein,et al.  Pulmonary endarterectomy , 2008, Current opinion in anaesthesiology.

[66]  G. Brooks,et al.  Defining hypoxia: a systems view of VO2, glycolysis, energetics, and intracellular PO2. , 1990, Journal of applied physiology.

[67]  Z. Safdar.  Phase 2 and 3 Clinical Trials in Pulmonary Arterial Hypertension , 2008 .

[68]  L. Olson,et al.  Parenchymal scarring is associated with restrictive spirometric defects in patients with chronic thromboembolic pulmonary hypertension. , 1996, Chest.

[69]  G. Meneely,et al.  THE VOLUME OF THE LUNG DETERMINED BY HELIUM DILUTION. DESCRIPTION OF THE METHOD AND COMPARISON WITH OTHER PROCEDURES. , 1949, The Journal of clinical investigation.

[70]  S. Ghio,et al.  Reverse right ventricular remodeling after pulmonary endarterectomy. , 2007, The Journal of thoracic and cardiovascular surgery.

[71]  D. Hess,et al.  Sildenafil can increase the response to inhaled nitric oxide. , 2000, Anesthesiology.

[72]  C. Chopin,et al.  Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies. , 1992, Chest.

[73]  S. Jamieson.  Pulmonary thromboendarterectomy , 1998, Heart.

[74]  J. Widimský,et al.  Longterm follow-up of patients with pulmonary thromboembolism. Late prognosis and evolution of hemodynamic and respiratory data. , 1982, Chest.

[75]  E. Pozzi,et al.  Long-term outcome after pulmonary endarterectomy. , 2008, American journal of respiratory and critical care medicine.

[76]  J. Hansen,et al.  Heparin blunts endotoxin-induced coagulation activation. , 1999, Circulation.

[77]  K. v. Neergaard,et al.  Neue Auffassungen über einen Grundbegriff der Atemmechanik , 1929 .

[78]  L. Dwyre,et al.  Thromboplastin Sensitivity in Waveform Analysis , 2000, Thrombosis and Haemostasis.

[79]  W. Baumgartner,et al.  Acute right ventricular failure following heart transplantation: improvement with prostaglandin E1 and right ventricular assist. , 1986, The Journal of heart transplantation.

[80]  S. Dymarkowski,et al.  Time course of reversed cardiac remodeling after pulmonary endarterectomy in patients with chronic pulmonary thromboembolism , 2008, European Radiology.

[81]  W. Hoots,et al.  The scoring system of the Scientific and Standardisation Committee on Disseminated Intravascular Coagulation of the International Society on Thrombosis and Haemostasis: a 5‐year overview 1 , 2007, Journal of thrombosis and haemostasis : JTH.

[82]  W. Webb.  High-resolution computed tomography of the lung: normal and abnormal anatomy. , 1991, Seminars in roentgenology.

[83]  M. Dolovich,et al.  Regional distribution of inspired gas in the lung. , 1966, Journal of applied physiology.

[84]  F. R. Smith.  Segmental anatomy as applied to segmental resection. , 1958, Diseases of the chest.

[85]  D. F. Wolfe,et al.  Comparison of published pressure gradient symbols and equations in mechanics of breathing. , 2006, Respiratory care.

[86]  C. Hogue,et al.  Vasopressin during spinal anesthesia in a patient with primary pulmonary hypertension treated with intravenous epoprostenol. , 2004, Anesthesia and analgesia.

[87]  T. Treasure,et al.  Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials. , 2004, The Journal of thoracic and cardiovascular surgery.

[88]  E. Favaloro.  Laboratory testing in disseminated intravascular coagulation. , 2010, Seminars in thrombosis and hemostasis.

[89]  A. Pavie,et al.  Preventing, minimizing, and managing postoperative bleeding. , 1999, The Annals of thoracic surgery.

[90]  W. Seeger,et al.  Aerosolized Prostacyclin and Iloprost in Severe Pulmonary Hypertension , 1996, Annals of Internal Medicine.

[91]  S. Nakamura,et al.  Neutrophils express tissue factor in a monkey model of sepsis. , 2000, Surgery.

[92]  J. Álvarez,et al.  Hemodynamic effects of prostaglandin E1 and isoproterenol early after cardiac operations for mitral stenosis. , 1992, The Journal of thoracic and cardiovascular surgery.

[93]  M. Levi.  Current understanding of disseminated intravascular coagulation , 2004, British journal of haematology.

[94]  E. Regoeczi,et al.  Organ Distribution of Fibrin in Disseminated Intravascular Coagulation , 1969, British journal of haematology.

[95]  S. Opal,et al.  Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. , 2001, JAMA.

[96]  K. Wrabec,et al.  Prognostic factors in medically treated patients with chronic pulmonary embolism. , 2001, Chest.

[97]  H. Shiku,et al.  Outcome of Disseminated Intravascular Coagulation in Relation to the Score when Treatment was Begun , 1995, Thrombosis and Haemostasis.

[98]  H. Iwanaga,et al.  Comprehensive Assessment of Lung CT Attenuation Alteration at Perfusion Defects of Acute Pulmonary Thromboembolism With Breath-Hold SPECT-CT Fusion Images , 2006, Journal of computer assisted tomography.

[99]  M. Levi.  The imbalance between tissue factor and tissue factor pathway inhibitor in sepsis. , 2002, Critical care medicine.

[100]  R. Coulden.  State-of-the-art imaging techniques in chronic thromboembolic pulmonary hypertension. , 2006, Proceedings of the American Thoracic Society.

[101]  H. Büller,et al.  Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: A systematic review , 2005, Critical care medicine.

[102]  R. Colman,et al.  Pathology of disseminated intravascular coagulation (DIC). Analysis of 26 cases. , 1972, Human pathology.

[103]  D. F. Rochester,et al.  Tests of respiratory muscle function. , 1988, Clinics in chest medicine.

[104]  D. Langleben.  Endothelin receptor antagonists in the treatment of pulmonary arterial hypertension. , 2007, Clinics in chest medicine.

[105]  Francisco Taboada,et al.  Comparative study of four sigmoid models of pressure-volume curve in acute lung injury , 2007, Biomedical engineering online.

[106]  Jeremiah R. Brown,et al.  Meta-Analysis Comparing the Effectiveness and Adverse Outcomes of Antifibrinolytic Agents in Cardiac Surgery , 2007, Circulation.

[107]  W. Auger,et al.  Perfusion techniques of profound hypothermia and circulatory arrest for pulmonary thromboendarterectomy , 1990 .

[108]  P Enright,et al.  Multiple-breath nitrogen washout techniques: including measurements with patients on ventilators. , 1997, The European respiratory journal.

[109]  G. Rodgers,et al.  Disseminated intravascular coagulation: Clinical and laboratory aspects , 1998, American journal of hematology.

[110]  José A Fernández,et al.  Prognostic value of protein C concentrations in neutropenic patients at high risk of severe septic complications , 2000, Critical care medicine.

[111]  M. Singer,et al.  The oxygen trail: tissue oxygenation. , 1999, British medical bulletin.

[112]  D. Ivy,et al.  Dipyridamole, a cGMP phosphodiesterase inhibitor, causes pulmonary vasodilation in the ovine fetus. , 1995, The American journal of physiology.

[113]  P. Thistlethwaite,et al.  Signaling molecules in nonfamilial pulmonary hypertension. , 2003, The New England journal of medicine.

[114]  S. Kushimoto,et al.  Natural history of disseminated intravascular coagulation diagnosed based on the newly established diagnostic criteria for critically ill patients: Results of a multicenter, prospective survey* , 2008, Critical care medicine.

[115]  T. Iba,et al.  [Disseminated intravascular coagulation]. , 2003, Nihon rinsho. Japanese journal of clinical medicine.

[116]  G. Viegi,et al.  Standardisation of the measurement of lung volumes , 2005, European Respiratory Journal.

[117]  R. Martineau,et al.  A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. , 2008, The New England journal of medicine.

[118]  Keyvan Karkouti,et al.  A propensity score case‐control comparison of aprotinin and tranexamic acid in high‐transfusion‐risk cardiac surgery , 2006, Transfusion.

[119]  C. Samama,et al.  Inhibition of Platelet Aggregation by Inhaled Nitric Oxide in Patients with Acute Respiratory Distress Syndrome , 1995, Anesthesiology.

[120]  C. Koebnick,et al.  Thrombocytopenia in patients in the medical intensive care unit: Bleeding prevalence, transfusion requirements, and outcome* , 2002, Critical care medicine.

[121]  B. Furie,et al.  Mechanisms of thrombus formation. , 2008, The New England journal of medicine.

[122]  M. Ray,et al.  Comparison of epsilon aminocaproic acid and low-dose aprotinin in cardiopulmonary bypass: efficiency, safety and cost. , 2001, The Annals of thoracic surgery.

[123]  S. Opal,et al.  Treatment effects of high‐dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation , 2006, Journal of thrombosis and haemostasis : JTH.

[124]  C. Esmon.  Role of Coagulation Inhibitors in Inflammation , 2001, Thrombosis and Haemostasis.

[125]  D. Feinstein.  Diagnosis and management of disseminated intravascular coagulation: the role of heparin therapy. , 1982, Blood.

[126]  P. Kumar,et al.  Prevention and treatment of major blood loss. , 2007, The New England journal of medicine.

[127]  C. Toh.  Transmittance waveform of routine coagulation tests is a sensitive and specific method for diagnosing non-overt disseminated intravascular coagulation. , 2002, Blood reviews.

[128]  R. Bick.  Disseminated Intravascular Coagulation: Pathophysiological Mechanisms and Manifestations , 1998, Seminars in thrombosis and hemostasis.

[129]  K. Oka,et al.  Distribution patterns of microthrombi in disseminated intravascular coagulation. , 1983, Archives of pathology & laboratory medicine.

[130]  S. Opal,et al.  Coagulation abnormalities in critically ill patients , 2006, Critical care.

[131]  E. Mammen,et al.  Disseminated intravascular coagulation (DIC). , 2000, Clinical laboratory science : journal of the American Society for Medical Technology.

[132]  E. Yi,et al.  Pulmonary thromboendarterectomy: a clinicopathologic study of 200 consecutive pulmonary thromboendarterectomy cases in one institution. , 2007, Human pathology.

[133]  R. Bick.  Disseminated intravascular coagulation current concepts of etiology, pathophysiology, diagnosis, and treatment. , 2003, Hematology/oncology clinics of North America.

[134]  K. Peterson,et al.  Cardiac catheterization techniques in pulmonary hypertension. , 2004, Cardiology clinics.

[135]  H. Shiku,et al.  Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation , 1996, American journal of hematology.

[136]  C. Poets,et al.  Conductive airway surfactant: surface-tension function, biochemical composition, and possible alveolar origin. , 1997, American journal of respiratory cell and molecular biology.

[137]  R. McIntyre,et al.  Effective control of refractory pulmonary hypertension after cardiac operations. , 1997, The Journal of thoracic and cardiovascular surgery.

[138]  J. Haitsma.  Physiology of mechanical ventilation. , 2007, Critical care clinics.

[139]  R. Michler,et al.  The evolving management of acute right-sided heart failure in cardiac transplant recipients. , 2001, Journal of the American College of Cardiology.

[140]  H. Schieffer,et al.  Acute effects of intravenous milrinone in heart failure. , 1989, European heart journal.

[141]  Priestley, the furious free thinker of the enlightenment, and Scheele, the taciturn apothecary of Uppsala , 2002, Acta anaesthesiologica Scandinavica.

[142]  M. Fujimaki.  [Diagnosis of disseminated intravascular coagulation]. , 1985, Rinsho byori. The Japanese journal of clinical pathology.

[143]  Kaoru Koike,et al.  Comparison of diagnostic criteria for disseminated intravascular coagulation (DIC): diagnostic criteria of the International Society of Thrombosis and Hemostasis (ISTH) and of the Japanese Ministry of Health and Welfare for overt DIC , 2003, American journal of hematology.

[144]  C. Toh,et al.  Early Identification and Prognostic Implications in Disseminated Intravascular Coagulation through Transmittance Waveform Analysis , 1998, Thrombosis and Haemostasis.

[145]  S. Gando,et al.  Cytokines and plasminogen activator inhibitor-1 in posttrauma disseminated intravascular coagulation: relationship to multiple organ dysfunction syndrome. , 1995, Critical care medicine.

[146]  C. Sprung,et al.  Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial. , 2003, JAMA.

[147]  C. Jackson,et al.  Correlated Applied Anatomy of the Bronchial Tree and Lungs With a System of Nomenclature , 1943 .

[148]  R. Naeije,et al.  Effects of levosimendan versus dobutamine on pressure load-induced right ventricular failure. , 2006, Critical care medicine.

[149]  K. F. Russell,et al.  Lectures on the Whole of Anatomy: An Annotated Translation of Prelectiones Anatomiae Universalis , 2012 .

[150]  R. Bick.  Disseminated Intravascular Coagulation and Related Syndromes: A Clinical Review , 1988, Seminars in thrombosis and hemostasis.